Blood-sugar markers linked to future mobility difficulties
An observational study of 13,650 people across three aging cohorts found the most consistent links for markers of blood-sugar regulation.
Limit: Medication-adjusted analyses gave mixed results, leaving possible confounding by medication use
Edited by Boris Djordjevic · AgingResearch.News
This observational study analyzed 13,650 participants without mobility limitation in the English Longitudinal Study of Ageing, China Health and Retirement Longitudinal Study, and Health and Retirement Study. Researchers defined new mobility limitation as difficulty with at least one mobility-related physical task at follow-up. They examined markers of blood pressure, blood sugar, blood fats and inflammation.
Blood-sugar markers showed the most consistent associations with new mobility limitation. Researchers also developed a four-marker score in the English cohort and tested it in the other two. Higher scores were associated with higher risk in all three cohorts. Stricter definitions of mobility limitation supported the associations, but analyses involving objective physical performance and medication adjustment gave mixed results. The score’s ability to distinguish who would develop mobility limitation was modest.
Why it matters
The study addressed whether metabolic health markers help identify the risk of declining physical function with age. The authors concluded that these markers capture a relevant but incomplete part of that risk.
Caveats
These observational associations do not show that blood-sugar dysfunction caused mobility difficulties. The findings concern people without mobility limitation at baseline, not those already experiencing it.
- Inflammation
- Lipid and ceramide metabolism
- Mobility limitation
- Biomarker-burden score
- C-reactive protein
- Humans
The paper
Guangdong Academy of Medical Sciences; Hospital Nacional de Parapléjicos
Experimental Gerontology, Jun 18, 2026, Open access
